pharmacare atropine sulphate injection
atropine sulphate 0.6mg - injection - atropine sulphate 0.6mg - antibacterials for systemic use
atropine sulphate s.a.l.f. 1 mgml
raz pharmaceutics ltd, israel - atropine sulfate - solution for injection - atropine sulfate 1 mg / 1 ml - atropine - preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. treatment of sinus bradycardia, particularly if complicated by hypotension.antidote in poisoning by organophosphorus.
atropine sulphate-fresenius 1mgml injection
fresenius kabi malaysia sdn. bhd - atropine sulphate -
atropine sulphate 600 micrograms/ml solution for injection
mercury pharma international limited 4045 kingswood road, city west business park, co, dublin, ireland - atropine sulfate - solution for injection - atropine sulfate 600 µg/ml - drugs for functional gastrointestinal disorders
atropine juno atropine sulfate monohydrate 600 microgram/1ml injection bp ampoule
juno pharmaceuticals pty ltd - atropine sulfate monohydrate, quantity: 600 microgram/ml; sodium hydroxide - injection, solution - excipient ingredients: water for injections; sodium chloride; sulfuric acid - indications as at 30 september 2003:surgery : atropine may be given as a pre-anaesthetic medication to inhibit excessive salivary and bronchial secretions and to diminish the risk of vagal inhibition of the heart. the use of atropine as an antisialogogue is rarely necessary since the introduction of halothane and similar anaesthetics in place of ether anaesthesia. after surgery atropine may also be administered concurrently with anticholinesterase agents (e.g. neostigmine, physostigmine) when used to terminate curarisation to counteract the adverse muscarinic effects of these drugs. cardiopulmonary resuscitation : atropine may be used during cardiopulmonary resuscitation to treat sinus bradycardia and associated hypotension, and increased ventricular irritability. anticholinesterase poisoning : atropine juno is also used in the treatment of sinus bradycardia induced by organophosphate pesticides, amanita muscaria mushrooms or other compounds with anticholinesterase activity. a cholinesterase reactivator, e.g. pralidoxime iodide, may be given concurrently.
atropine sulphate fresenius 0,5 mg / 1 ml
fresenius kabi manufacturing (sa) (pty) ltd - atropine sulphate - injectable solution - atropine sulphate 0.5 mg/ 1 ml
atropine sulphate fresenius 0.6 mg / 1 ml
fresenius kabi manufacturing (sa) (pty) ltd - atropine sulphate - injectable solution - atropine sulphate 0.6 mg/1 ml
minims atropine sulphate 1% 10 mg/ml eye drops tube
bausch & lomb australia pty ltd - atropine sulfate monohydrate, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; purified water - to produce mydriasis and cycloplegia
atropine sulphate
aspen pharma pty ltd - atropine sulfate monohydrate, quantity: 600 microgram - tablet, uncoated - excipient ingredients: povidone; lactose monohydrate; maize starch; purified talc; magnesium stearate - for the treatment of muscarinic toxicity resulting from exposure to anticholinesterase compounds (e.g. organophosphate pesticides). atropine tablets are not as effective as i.v. atropine, which is almost always required for significant organophosphate poisoning. however atropine tablets are of value when medical assistance is not readily available, and is indicated as a short term antidote pending access to professional medical treatment. atropine tablets are not recommended for prophylaxis for pesticide poisoning. atropine does not prevent pesticide poisoning; attempts to use atropine tablets for this purpose have lead to several cases of mild atropine poisoning as well as chronic organophosphate poisoning.
min-i-jet atropine sulphate 1mg/10ml injection syringe vial
bppr consulting - atropine sulfate monohydrate -